18 de 0ctubre de 2010 www.elsuapdetodos.com1334 C.D. Deakin et al. / <strong>Resuscitation</strong> 81 (2010) 1305–1352discharge, the vast majority have a good neurological outcomealthough many with some cognitive impairment. 639Post-cardiac arrest syndromeObtain a chest radiograph to check the position of the tracheal tubeand central venous lines, assess <strong>for</strong> pulmonary oedema, and detectcomplications from <strong>CPR</strong> such as a pneumothorax associated withrib fractures.The post-cardiac arrest syndrome comprises post-cardiac arrestbrain injury, post-cardiac arrest myocardial dysfunction, thesystemic ischaemia/reperfusion response, and the persistent precipitatingpathology. 628 The severity of this syndrome will varywith the duration and cause of cardiac arrest. It may not occurat all if the cardiac arrest is brief. Post-cardiac arrest brain injurymanifests as coma, seizures, myoclonus, varying degrees of neurocognitivedysfunction and brain death. Among patients survivingto ICU admission but subsequently dying in-hospital, brain injury isthe cause of death in 68% after out-of hospital cardiac arrest and in23% after in-hospital cardiac arrest. 245,640 Post-cardiac arrest braininjury may be exacerbated by microcirculatory failure, impairedautoregulation, hypercarbia, hyperoxia, pyrexia, hyperglycaemiaand seizures. Significant myocardial dysfunction is common aftercardiac arrest but typically recovers by 2–3 days. 641,642 The wholebody ischaemia/reperfusion of cardiac arrest activates immunologicaland coagulation pathways contributing to multiple organfailure and increasing the risk of infection. 643,644 Thus, the postcardiacarrest syndrome has many features in common with sepsis,including intravascular volume depletion and vasodilation. 645,646Airway and breathingPatients who have had a brief period of cardiac arrest respondingimmediately to appropriate treatment may achieve an immediatereturn of normal cerebral function. These patients do not requiretracheal intubation and ventilation but should be given oxygen viaa facemask. Hypoxaemia and hypercarbia both increase the likelihoodof a further cardiac arrest and may contribute to secondarybrain injury. Several animal studies indicate that hyperoxaemiacauses oxidative stress and harms post-ischaemic neurones. 647–650One animal study has demonstrated that adjusting the fractionalinspired concentration (FiO 2 ) to produce an arterial oxygensaturation of 94–96% in the first hour after ROSC (‘controlled reoxygenation’)achieved better neurological outcomes than achievedwith the delivery of 100% oxygen. 328 A recent clinical registry studythat included more than 6000 patients supports the animal data andshows post-resuscitation hyperoxaemia is associated with worseoutcome, compared with both normoxaemia and hypoxaemia. 329In clinical practice, as soon as arterial blood oxygen saturation canbe monitored reliably (by blood gas analysis and/or pulse oximetry),it may be more practicable to titrate the inspired oxygenconcentration to maintain the arterial blood oxygen saturation inthe range of 94–98%.Consider tracheal intubation, sedation and controlled ventilationin any patient with obtunded cerebral function. Ensurethe tracheal tube is positioned correctly well above the carina.Hypocarbia causes cerebral vasoconstriction and a decreased cerebralblood flow. 651 After cardiac arrest, hypocapnoea induced byhyperventilation causes cerebral ischaemia. 652–655 There are nodata to support the targeting of a specific arterial PCO 2 after resuscitationfrom cardiac arrest, but it is reasonable to adjust ventilationto achieve normocarbia and to monitor this using the end-tidalPCO 2 and arterial blood gas values.Insert a gastric tube to decompress the stomach; gastric distensioncaused by mouth-to-mouth or bag-mask-valve ventilation willsplint the diaphragm and impair ventilation. Give adequate doses ofsedative, which will reduce oxygen consumption. Bolus doses of aneuromuscular blocking drug may be required, particularly if usingtherapeutic hypothermia (see below), but try to avoid infusions ofneuromuscular blocking drugs because these may mask seizures.CirculationThe majority of out-of-hospital cardiac arrest patients havecoronary artery disease. 656,657 Acute changes in coronary plaquemorphology occur in 40–86% of cardiac arrest survivors and in15–64% of autopsy studies. 658 It is well recognised that postcardiacarrest patients with ST elevation myocardial infarction(STEMI) should undergo early coronary angiography and percutaneouscoronary intervention (PCI) but, because chest painand/or ST elevation are poor predictors of acute coronary occlusionin these patients, 659 this intervention should be consideredin all post-cardiac arrest patients who are suspected of havingcoronary artery disease. 629,633,659–665 Several studies indicatethat the combination of therapeutic hypothermia and PCI is feasibleand safe after cardiac arrest caused by acute myocardialinfarction. 629,633,638,665,666Post-cardiac arrest myocardial dysfunction causes haemodynamicinstability, which manifests as hypotension, low cardiacindex and arrhythmias. 641 Early echocardiography will enable thedegree of myocardial dysfunction to be quantified. 642 In the ICUan arterial line <strong>for</strong> continuous blood pressure monitoring is essential.Treatment with fluid, inotropes and vasopressors may beguided by blood pressure, heart rate, urine output, and rate ofplasma lactate clearance and central venous oxygen saturations.Non-invasive cardiac output monitors may help to guide treatmentbut there is no evidence that their use affects outcome. Iftreatment with fluid resuscitation and vasoactive drugs is insufficientto support the circulation, consider insertion of an intra-aorticballoon pump. 629,638 Infusion of relatively large volumes of fluidsare tolerated remarkably well by patients with post-cardiacarrest syndrome. 513,629,630,641 Although early goal directed therapyis well-established in the treatment of sepsis, 667 and hasbeen proposed as a treatment strategy after cardiac arrest, 630there are no randomised, controlled data to support its routineuse.There are very few randomised trials evaluating the role ofblood pressure on the outcome after cardiac arrest. One randomisedstudy demonstrated no difference in the neurological outcomeamong patients randomised to a mean arterial blood pressure(MAP) of >100 mm Hg versus ≤100 mm Hg 5 min after ROSC; however,good functional recovery was associated with a higher bloodpressure during the first 2 h after ROSC. 668 In a registry study ofmore than 6000 post-cardiac arrest patients, hypotension (systolicblood pressure
18 de 0ctubre de 2010 www.elsuapdetodos.comC.D. Deakin et al. / <strong>Resuscitation</strong> 81 (2010) 1305–1352 1335Disability (optimising neurological recovery)Cerebral perfusionImmediately after ROSC there is a period of cerebralhyperaemia. 670 After asphyxial cardiac arrest, brain oedema mayoccur transiently after ROSC but it is rarely associated with clinicallyrelevant increases in intracranial pressure. 671,672 Autoregulation ofcerebral blood flow is impaired <strong>for</strong> some time after cardiac arrest,which means that cerebral perfusion varies with cerebral perfusionpressure instead of being linked to neuronal activity. 673,674 As discussedpreviously, following ROSC, maintain mean arterial pressurenear the patient’s normal level.Sedationwith intensive glucose control. 688 Another recent study and twometa-analyses of studies of tight glucose control versus conventionalglucose control in critically ill patients showed no significantdifference in mortality but found tight glucose control was associatedwith a significantly increased risk of hypoglycaemia. 689–691Severe hypoglycaemia is associated with increased mortality incritically ill patients, 692 and comatose patients are at particularrisk from unrecognised hypoglycaemia. There is some evidencethat, irrespective of the target range, variability in glucose values isassociated with mortality. 693Based on the available data, following ROSC blood glucoseshould be maintained at ≤10 mmol l −1 (180 mg dl −1 ). 694 Hypoglycaemiashould be avoided. Strict glucose control should notbe implemented in adult patients with ROSC after cardiac arrestbecause of the increased risk of hypoglycaemia.Although it has been common practice to sedate and ventilatepatients <strong>for</strong> at least 24 h after ROSC, there are no high-level data tosupport a defined period of ventilation, sedation and neuromuscularblockade after cardiac arrest. Patients need to be well-sedatedduring treatment with therapeutic hypothermia, and the durationof sedation and ventilation is there<strong>for</strong>e influenced by this treatment.There are no data to indicate whether or not the choiceof sedation influences outcome, but a combination of opioidsand hypnotics is usually used. Short-acting drugs (e.g., propofol,alfentanil, remifentanil) will enable earlier neurological assessment.Adequate sedation will reduce oxygen consumption. Duringhypothermia, optimal sedation can reduce or prevent shivering,which enable the target temperature to be achieved more rapidly.Use of published sedation scales <strong>for</strong> monitoring these patients (e.g.,the Richmond or Ramsay Scales) may be helpful. 675,676Control of seizuresSeizures or myoclonus or both occur in 5–15% of adultpatients who achieve ROSC and 10–40% of those who remaincomatose. 498,677–680 Seizures increase cerebral metabolism by upto 3-fold 681 and may cause cerebral injury: treat promptly andeffectively with benzodiazepines, phenytoin, sodium valproate,propofol, or a barbiturate. Myoclonus can be particularly difficult totreat; phenytoin is often ineffective. Clonazepam is the most effectiveantimyoclonic drug, but sodium valproate, levetiracetam andpropofol may also be effective. 682 Maintenance therapy should bestarted after the first event once potential precipitating causes (e.g.,intracranial haemorrhage, electrolyte imbalance) are excluded. Nostudies directly address the use of prophylactic anticonvulsantdrugs after cardiac arrest in adults.Glucose controlThere is a strong association between high blood glucoseafter resuscitation from cardiac arrest and poor neurologicaloutcome. 498–501,504,634,683,684 Although one randomised controlledtrial in a cardiac surgical intensive care unit showed that tight controlof blood glucose (4.4–6.1 mmol l −1 or 80–110 mg dl −1 ) usinginsulin reduced hospital mortality in critically ill adults, 685 a secondstudy by the same group in medical ICU patients showedno mortality benefit from tight glucose control. 686 In one randomisedtrial of patients resuscitated from OHCA with ventricularfibrillation, strict glucose control (72–108 mg dl −1 , 4–6 mmol l −1 ])gave no survival benefit compared with moderate glucose control(108–144 mg dl −1 , 6–8 mmol l −1 ) and there were more episodes ofhypoglycaemia in the strict glucose control group. 687 A large randomisedtrial of intensive glucose control (4.5–6.0 mmol l −1 ) versusconventional glucose control (10 mmol l −1 or less) in general ICUpatients reported increased 90-day mortality in patients treatedTemperature controlTreatment of hyperpyrexiaA period of hyperthermia (hyperpyrexia) is common in thefirst 48 h after cardiac arrest. 695–697 Several studies documentan association between post-cardiac arrest pyrexia and pooroutcomes. 498,695,697–700 There are no randomised controlled trialsevaluating the effect of treatment of pyrexia (defined as ≥37.6 ◦ C)compared to no temperature control in patients after cardiac arrest.Although the effect of elevated temperature on outcome is notproved, it seems prudent to treat any hyperthermia occurring aftercardiac arrest with antipyretics or active cooling.Therapeutic hypothermiaAnimal and human data indicate that mild hypothermia isneuroprotective and improves outcome after a period of globalcerebral hypoxia-ischaemia. 701,702 Cooling suppresses many ofthe pathways leading to delayed cell death, including apoptosis(programmed cell death). Hypothermia decreases the cerebralmetabolic rate <strong>for</strong> oxygen (CMRO 2 ) by about 6% <strong>for</strong> each 1 ◦ C reductionin temperature 703 and this may reduce the release of excitatoryamino acids and free radicals. 701 Hypothermia blocks the intracellularconsequences of excitotoxin exposure (high calcium andglutamate concentrations) and reduces the inflammatory responseassociated with the post-cardiac arrest syndrome.Which post-cardiac arrest patients should be cooled?. All studiesof post-cardiac arrest therapeutic hypothermia have includedonly patients in coma. There is good evidence supporting the useof induced hypothermia in comatose survivors of out-of-hospitalcardiac arrest caused by VF. One randomised trial 704 and a pseudorandomisedtrial 669 demonstrated improved neurological outcomeat hospital discharge or at 6 months in comatose patients afterout-of-hospital VF cardiac arrest. Cooling was initiated within minutesto hours after ROSC and a temperature range of 32–34 ◦ C wasmaintained <strong>for</strong> 12–24 h. Two studies with historical control groupsshowed improvement in neurological outcome after therapeutichypothermia <strong>for</strong> comatose survivors of VF cardiac arrest. 705–707Extrapolation of these data to other cardiac arrests (e.g., other initialrhythms, in-hospital arrests, paediatric patients) seems reasonablebut is supported by only lower level data.One small, randomised trial showed reduced plasma lactatevalues and oxygen extraction ratios in a group of comatose survivorsafter cardiac arrest with asystole or PEA who were cooledwith a cooling cap. 708 Six studies with historical control groupshave shown benefit using therapeutic hypothermia in comatosesurvivors of OHCA after all rhythm arrests. 629,632,709–712 Two nonrandomisedstudies with concurrent controls indicate possiblebenefit of hypothermia following cardiac arrest from other initialrhythms in- and out-of-hospital. 713,714www.elsuapdetodos.com